FDA Publishes First Draft Guidance On Psychedelic Drug Trials

By Lia DeGroot / June 23, 2023 at 5:52 PM

FDA on Friday (June 23) published its first draft guidance on clinical trials for psychedelic drugs, coming as research into use of psychedelics to treat conditions like depression and post-traumatic stress disorder becomes increasingly widespread.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.